BP
Bhikhabhai Patel Dahyalal
About Bhikhabhai Patel Dahyalal
Data last updated:
Bhikhabhai Patel Dahyalal was a Director at Ryzer Pharmaceutical Private Limited (2018–2024) and Director at Accupharm Pharmaceuticals Private Limited (from 2017). The companies operate in Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Oct 2018 | 2018 | ₹7.71 Cr (FY 2025) | Active | |
| Director | 01 Feb 2017 | 2017 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhikhabhai Patel Dahyalal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhikhabhai Patel Dahyalal
Bhikhabhai Patel Dahyalal was first appointed on 01 Feb 2017 as Director at Accupharm Pharmaceuticals Private Limited. The most recent appointment on record is 01 Oct 2018 at Ryzer Pharmaceutical Private Limited.
Bhikhabhai Patel Dahyalal held 2 earlier board appointments: Ryzer Pharmaceutical Private Limited (Director, 01 Oct 2018 to 26 Mar 2024); Accupharm Pharmaceuticals Private Limited (Director, from 01 Feb 2017).